↓ Skip to main content

FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragmin®added to standard therapy in patients with lung cancer

Overview of attention for article published in BMC Cancer, October 2009
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
52 Dimensions

Readers on

mendeley
121 Mendeley